fingolimod hydrochloride has been researched along with Acquired Form of Epidermolysis Bullosa in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bieber, K; Hauenschild, E; Kalies, K; Kasperkiewicz, M; Ludwig, RJ; Maass, S; Niebuhr, M; Westermann, J | 1 |
| Bieber, K; Gupta, Y; Kalies, K; Ludwig, RJ; Mousavi, S; Sadik, CD; Sezin, T; Thieme, M; Wannick, M; Zillikens, D | 1 |
2 other study(ies) available for fingolimod hydrochloride and Acquired Form of Epidermolysis Bullosa
| Article | Year |
|---|---|
Evidence for a contributory role of a xenogeneic immune response in experimental epidermolysis bullosa acquisita.
Topics: Animals; Antibodies, Heterophile; Collagen Type VII; Disease Models, Animal; Epidermolysis Bullosa Acquisita; Fingolimod Hydrochloride; Immunoglobulin G; Interferon-gamma; Lymph Nodes; Mice, Inbred C57BL; Rabbits; T-Lymphocytes | 2017 |
The Sphingosine-1-Phosphate Receptor Modulator Fingolimod Aggravates Murine Epidermolysis Bullosa Acquisita.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Cells, Cultured; Collagen Type VII; Disease Models, Animal; Epidermolysis Bullosa Acquisita; Fingolimod Hydrochloride; Forkhead Transcription Factors; Humans; Inflammation; Interleukin-10; Intraepithelial Lymphocytes; Mice; Neutrophils; Skin; Sphingosine-1-Phosphate Receptors; T-Lymphocytes, Regulatory | 2019 |